Intrinsiqs

Is Castle Biosciences, Inc. overvalued?

Castle Biosciences, Inc. (CSTL) — key valuation metrics and fundamentals.

No verdict
Price
$35.93
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.10B
Dividend yield
0.0%
Return on equity
-4.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CSTL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.